Clerc, G. E., Ruimy, P., & Verdeau-Pailles, J. A. (1994). A doubleblind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. International Clinical of Psychopharmacology, 9, 139-143.
2.
Cunningham, L. A., Borison, R. L., Carman J. S., Chouinard, G., Crowder, J. E., Diamond, G. I., Fischer, D. E., & Hearst, E. (1994). A comparison of venlafaxine, trazodone, and placebo in major depression. Journal of Clinical Psychopharmacology, 14, 99-106.
3.
Derivan, A., Entsuah, A.R., & Kikta, D. (1995). Venlafaxine: Measuring the onset of antidepressant action. Psychopharmacological Bulletin, 31, 439-447.
4.
Dillon, C.L., & Lopez, J. R. (1996). Clinical drug evaluation: Venlafaxine. Federal Practitioner, 13(2), 32-34.
5.
Greenberg, P.E., Stiglin, L.E., Finkelstein, S. N., & Berndt, E.R. (1993a). The economic burden of depression in 1990. Journal of Clinical Psychiatry, 54, 405-418.
6.
Greenberg P.E., Stiglin, L. E., Finkelstein, S. N., & Berndt, E. R. (1993b) Depression: a neglected major illness. Journal of Clinical Psychiatry, 54, 419-424.
7.
Keltner, N. L. (1995). Venlafaxine: A novel antidepressant. Journal of Psychosocial Nursing and Mental Health Services, 33(1), 51-51, 52-52, C3-C3.
8.
Montgomery, S. A. (1993). Venlafaxine: A new dimension in antidepressant pharmacotherapy. Journal of Clinical Psychiatry, 54, 119-126.
9.
Muth, E. A., Haskins, J. T., Moyer, J. A., Husbands, G. E. M., Nielsen, S. T., & Sigg, E.B. (1986). Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochemical Pharmacology, 35, 4493-4497.
10.
New drug bulletin. (1994). FDA approved new drug bulletin: Venlafaxine hydrochloride (Effexor). RN, 57(10), 51-52.
11.
Reeves, R.A. (1995). Does this patient have hypertension? How to measure BP. Journal of American Medical Association, 273, 1211-1218.
12.
Santiago, J. M. (1993). Commentary: The cost of treating depression. Journal of Clinical Psycbiatry, 54, 425-426.
13.
Shrivastava, R. K., Cohn, C., Crowder, J., Davidson, J., Donner, D., Feighner, J., Kiev, A., & Patrick, R. (1994). Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. Journal of Clinical Psychopharmacology, 14, 322-329.
14.
U. S. Department of Health and Human Services. (1993). Depression in primary care: Volume 2. Treatment of major depression (AHCPR Publication No. 93-0551). Rockville, MD: U. S. Government Printing Office.
15.
Wells, K. B. & Burnam, M. A. (1991). Caring for depression in America: Lessons learned from early findings of medical outcomes study. Psychiatric Medicine, 9, 503-519.
